Target Information

Danish company Demant is one of the world's leading manufacturers of hearing aids, holding a global market share of over 20 percent. The business operates on three main fronts: hearing aids account for 45 percent of revenue, the Audika hearing clinic sector represents 40 percent with over 4,000 clinics worldwide, and the diagnostics segment contributes 11 percent.

The global hearing aid market is valued at approximately $7 billion, with Demant estimating an annual growth rate of around 4 to 6 percent. Key drivers of this growth include an aging population and an increasing adoption rate of hearing aids.

Industry Overview

The hearing aid industry exhibits a cyclical pattern, transitioning through five-year intervals of market demand influenced by health reimbursement policies in various countries. This fluctuation reflects market dynamics; for inst

View Source

Similar Deals

Janus Henderson Group Plc Medios AG

2025

Other Proprietary & Advanced Pharmaceuticals Germany
Sandoz AG Just – Evotec Biologics

2025

Other Bio Therapeutic Drugs Germany
KARL STORZ Diaspective Vision

2025

Other Medical Imaging Systems Germany
Venrock Healthcare Capital Partners Tubulis

2025

Other Bio Therapeutic Drugs Germany
refactory Bleicher GmbH

2025

Other Advanced Medical Equipment & Technology (NEC) Germany

Demant

invested in

KIND

in 2026

in a Other deal

Disclosed details

Transaction Size: $748M

Revenue: $317M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert